AstraZeneca Korea Completes Reorganization of Business Units

Published: 2005-01-18 06:57:00

Updated: 2005-01-18 06:57:00

With the total revenue surpassing over 100 billion won from last year, AstraZeneca Korea recently completed a reorganization of company functions under its plan to drive growth on a long-term basis.

According to the company spokesperson, the stated reorganization effort has generated a formati...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK